[Renocerebral oxalosis after xylitol therapy].
D000328:Adult; D001921:Brain / Q000378:metabolism*; D001928:Brain Diseases, Metabolic / Q000139:chemically induced* / Q000378:metabolism; D003460:Crystallization; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007668:Kidney / Q000378:metabolism*; D007674:Kidney Diseases / Q000139:chemically induced* / Q000378:metabolism; D010070:Oxalates / Q000378:metabolism*; D014993:Xylitol / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D010070:Oxalates; D014993:Xylitol
Renocerebral oksalose efter xylitolinfusion.